Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]

ASEM 文献综述

Official National Advisory Committee on Immunization document (2022) on “Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]”. NACI recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age: Methods, epidemiology, vaccine coverage, hybrid immunity, efficacy, immunogenicity, administration, safety, adverse events and more.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。